⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 1, 2001The Journal of Clinical Endocrinology & MetabolismOpen Access

Diabetic Dyslipidemia: Causes and Consequences

View Full Paper

Ask AI

Bookmark

Share

Authors

IGIra J. GoldbergPreventive Cardiology

Discussion

Loading...

Member takes

Implication

Diabetic dyslipidemia may flag future diabetes and CVD risk; leaves open causal lipoprotein pathways for targeted study.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ira J. Goldberg (2001) studied this question.

synapsesocial.com/papers/69d961da5e5bcb4e3b835ee2 https://doi.org/10.1210/jcem.86.3.7304

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes.1990 · 254 citations
2Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B.1991 · 420 citations
3Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice2000 · 104 citations
4Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk1994 · 233 citations
5Relations of body habitus, fitness level, and cardiovascular risk factors including lipoproteins and apolipoproteins in a rural and urban Costa Rican population.1991 · 69 citations